EGLN2 and cancer: However, subgroup analysis based on cancer type showed that EGLN2 rs10680577 polymorphism was significantly associated with the risk of digestive system cancer under all genetic models, and with the risk of lung cancer under dominant model, heterozygote comparison model, and allele comparison model.